Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000101

Chairperson & CEO sold 9,500 shares at an average $537.05 ($5,101,939)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-17 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-07-17 Sale : show line 2 in the form 10b5-1 −240 $528.91 $126,938 333,703 I
2026-07-17 Sale : show line 3 in the form 10b5-1 −240 $530.83 $127,400 333,463 I
2026-07-17 Sale : show line 4 in the form 10b5-1 −720 $534.57 $384,889 332,743 I
2026-07-17 Sale : show line 5 in the form 10b5-1 −2,350 $535.53 $1,258,486 330,393 I
2026-07-17 Sale : show line 6 in the form 10b5-1 −2,110 $536.36 $1,131,717 328,283 I
2026-07-17 Sale : show line 7 in the form 10b5-1 −1,160 $537.45 $623,438 327,123 I
2026-07-17 Sale : show line 8 in the form 10b5-1 −423 $538.70 $227,871 326,700 I
Open-market sales · 9,500 sh · avg $537.05 · $5,101,939

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-17 Exercise or conversion : show line 13 in the form 10b5-1 Stock Option −9,500 322,410 I
Loading xslF345X06/primarydocument.xml…